Core Viewpoint - The company emphasizes its commitment to sustainable development and technological innovation, aiming to enhance both economic and social value in the healthcare industry [1] Group 1: Internationalization and Product Innovation - The company focuses on core business areas such as cardiovascular intervention, health protection, and emergency rescue, leveraging strong R&D capabilities to introduce medical products that meet international market demands [2] - The company has established a multinational medical device platform, with 61 subsidiaries in over 20 countries and regions, and has developed a global R&D system with over 600 technical personnel [2] - In 2024, the company plans to develop nearly 60 new products, including innovative medical devices and treatments, showcasing its strong R&D strength and ability to meet market needs [3] Group 2: Industry Chain Collaboration and Green Technology - The company actively promotes industry chain collaboration to accelerate the transformation and application of innovative results, including a strategic partnership with Wanhua Chemical to explore new product applications [4] - The company has made significant progress in reducing production costs and improving product competitiveness through collaborations with educational institutions and technological upgrades [4] Group 3: Environmental Initiatives and Efficiency Improvements - The company invested approximately 188.34 million yuan in environmental protection, accounting for 3.01% of its revenue, while optimizing production processes to enhance efficiency [5] - The company has implemented changes in production methods, such as replacing ceramic hand molds with metal molds, resulting in a 30% reduction in energy consumption and significant coal savings [5] - The annual production capacity of nitrile gloves across several subsidiaries reaches 20.07 billion pieces, with potential coal savings of 46,161 tons if all ceramic molds are replaced [5]